Pages that link to "Q89115325"
Jump to navigation
Jump to search
The following pages link to Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis (Q89115325):
Displaying 22 items.
- Hepatocyte-Derived Lipotoxic Extracellular Vesicle Sphingosine 1-Phosphate Induces Macrophage Chemotaxis (Q60947050) (← links)
- Nutritional and lipidomics biomarkers of docosahexaenoic acid-based multivitamin therapy in pediatric NASH (Q61796232) (← links)
- Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis (Q64057135) (← links)
- 2, 3, 4′, 5-tetrahydroxystilbene-2-0-β-d Glycoside Attenuates Age- and Diet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDL Receptor Knockout Mice and Its Possible Mechanisms (Q64093625) (← links)
- Detection of DNA damage response in nonalcoholic fatty liver disease via p53-binding protein 1 nuclear expression (Q64114918) (← links)
- CRLS1 ameliorates nonalcoholic steatohepatitis through ATF3 transcriptional inactivation (Q89873416) (← links)
- Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis (Q90047443) (← links)
- Anti-Obesity Effects of the Flower of Prunus persica in High-Fat Diet-Induced Obese Mice (Q90079419) (← links)
- Variations in hepatic lipid species of age-matched male mice fed a methionine-choline-deficient diet and housed in different animal facilities (Q90107135) (← links)
- The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis (Q91089920) (← links)
- Maternal diet intervention before pregnancy primes offspring lipid metabolism in liver (Q91362472) (← links)
- Pathogenesis of Nonalcoholic Steatohepatitis: An Overview (Q91657975) (← links)
- Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy (Q91854913) (← links)
- Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress (Q92003593) (← links)
- Lipotoxicity in Kidney, Heart, and Skeletal Muscle Dysfunction (Q92081649) (← links)
- Comparative RNA-sequencing profiled the differential gene expression of liver in response to acetyl-CoA carboxylase inhibitor GS-0976 in a mouse model of NASH (Q92267409) (← links)
- Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma (Q92443564) (← links)
- Ataxia telangiectasia mutated pathway disruption affects hepatic DNA and tissue damage in nonalcoholic fatty liver disease (Q92514832) (← links)
- Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes (Q94479681) (← links)
- The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet (Q97871574) (← links)
- An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease (Q98178483) (← links)
- Prenatal Exposure to Perfluoroalkyl Substances Associated with Increased Susceptibility to Liver Injury in Children (Q98185257) (← links)